Effect of interleukin-6 deficiency on the formation of periapical lesions after pulp exposure in mice

Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics

Volumn 92, Issue 1, 2001, Pages 83-88

  Huang, George T J ^a   Do, Michael ^a   Wingard, Margaret ^a   Park, Jin S ^a   Chugal, Nadia ^a  

^a UCLA SCHOOL OF DENTISTRY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6;

ANALYSIS OF VARIANCE; ANIMAL; ARTICLE; C57BL MOUSE; DISEASE MODEL; ENDODONTICS; FIBROBLAST; GENE DELETION; GENETICS; HOMOZYGOTE; IMMUNOLOGY; LYMPHOCYTE; MACROPHAGE; MOUSE; MOUSE MUTANT; MOUSE STRAIN; MUTATION; NEUTROPHIL; OSTEOCLAST; OSTEOLYSIS; PATHOLOGY; STATISTICS; TOOTH PERIAPICAL DISEASE; TOOTH PULP;

ANALYSIS OF VARIANCE; ANIMALS; BONE RESORPTION; DENTAL PULP CAVITY; DENTAL PULP EXPOSURE; DISEASE MODELS, ANIMAL; FIBROBLASTS; GENE DELETION; HOMOZYGOTE; INTERLEUKIN-6; LYMPHOCYTES; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, INBRED STRAINS; MICE, KNOCKOUT; MUTATION; NEUTROPHILS; OSTEOCLASTS; PERIAPICAL ABSCESS; PERIAPICAL DISEASES; PERIAPICAL GRANULOMA; PERIAPICAL PERIODONTITIS; STATISTICS;

EID: 0035408305     PISSN: 10792104     EISSN: None     Source Type: Journal    
DOI: 10.1067/moe.2001.115025     Document Type: Article

References (37)

1. Akira S, Taga T, Kishimoto T. Interleukin-6 in biology and medicine. Adv Immunol 1993;54:1-78.
2. van Deventer SJ, Buller HR, Ten Cate JW, Aarden LA, Hack CE, Sturk A. Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic, and complement pathways. Blood 1990;76:2520-6.
3. Hesse DG, Tracey KJ, Fong Y, Manogue KR, Palladino MA Jr, Cerami A, et al. Cytokine appearance in human endotoxemia and primate bacteremia. Surg Gynecol Obstet 1988;166:147-53.
4. Schindler R, Mancilla J, Endres S, Ghorbani R, Clark SC, Dinarello CA. Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. Blood 1990;75:40-7.
5. Romani L, Mencacci A, Cenci E, Spaccapelo R, Toniatti C, Puccetti P, et al. Impaired neutrophil response and CD4+ T helper cell 1 development in interleukin 6-deficient mice infected with Candida albicans. J Exp Med 1996;183:1345-55.
6. Dalrymple SA, Lucian LA, Slattery R, McNeil T, Aud DM, Fuchino S, et al. Interleukin-6-deficient mice are highly susceptible to Listeria monocytogenes infection: correlation with inefficient neutrophilia. Infect Immun 1995;63:2262-8.
7. Kopf M, Baumann H, Freer G, Freudenberg M, Lamers M, Kishimoto T, et al. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 1994;368:339-42.
8. Yoshimoto T, Nakanishi K, Hirose S, Hiroishi K, Okamura H, Takemoto Y, et al. High serum IL-6 level reflects susceptible status of the host to endotoxin and IL-1/tumor necrosis factor. J Immunol 1992;148:3596-603.
9. Suzuki Y, Yang Q, Conley FK, Abrams JS, Remington JS. Antibody against interleukin-6 reduces inflammation and numbers of cysts in brains of mice with toxoplasmic encephalitis. Infect Immun 1994;62:2773-8.
10. Ishimi Y, Miyaura C, Jin CH, Akatsu T, Abe E, Nakamura Y, et al. IL-6 is produced by osteoblasts and induces bone resorption. J Immunol 1990;145:3297-303.
11. Binkley NC, Sun WH, Checovich MM, Roecker EB, Kimmel DB, Ershler WB. Effects of recombinant human interleukin-6 administration on bone in rhesus monkeys. Lymphokine Cytokine Res 1994;13:221-6.
12. Girasole G, Jilka RL, Passeri G, Boswell S, Boder G, Williams DC, et al. 17 beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens. J Clin Invest 1992;89:883-91.
13. Passeri G, Girasole G, Manolagas SC, Jilka RL. Endogenous production of tumor necrosis factor by primary cultures of murine calvarial cells: influence on IL-6 production and osteoclast development. Bone Miner 1994;24:109-26.
14. Papanicolaou DA, Wilder RL, Manolagas SC, Chrousos GP. The pathophysiologic roles of interleukin-6 in human disease. Ann Intern Med 1998;128:127-37.
15. Poli V, Balena R, Fattori E, Markatos A, Yamamoto M, Tanaka H, et al. Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO J 1994;13:1189-96.
16. Barkhordar RA, Hayashi C, Hussain MZ. Detection of interleukin-6 in human dental pulp and periapical lesions. Endod Dent Traumatol 1999;15:26-7.
17. Irwin CR, Myrillas TT. The role of IL-6 in the pathogenesis of periodontal disease. Oral Dis 1998;4:43-7.
18. Stashenko P, Teles R, D'Souza R. Periapical inflammatory responses and their modulation. Crit Rev Oral Biol Med 1998;9:498-521.
19. Takahashi K. Microbiological, pathological, inflammatory, immunological and molecular biological aspects of periradicular disease. Int Endodont J 1998;31:311-25.
20. Kawashima N, Stashenko P. Expression of bone-resorptive and regulatory cytokines in murine periapical inflammation. Arch Oral Biol 1999;44:55-66.
21. Chen CP, Hertzberg M, Jiang Y, Graves DT. Interleukin-1 and tumor necrosis factor receptor signaling is not required for bacteria-induced osteoclastogenesis and bone loss but is essential for protecting the host from a mixed anaerobic infection. Am J Pathol 1999;155:2145-52.
22. Wallstrom JB, Torabinejad M, Kettering J, McMillan P. Role of T cells in the pathogenesis of periapical lesions. A preliminary report. Oral Surg Oral Med Oral Pathol 1993;76:213-8.
23. Tani N, Kuchiba K, Osada T, Watanabe Y, Umemoto T. Effect of T-cell deficiency on the formation of periapical lesions in mice: histological comparison between periapical lesion formation in BALB/c and BALB/c nu/nu mice. J Endod 1995;21:195-9.
24. Teles R, Wang CY, Stashenko P. Increased susceptibility of RAG-2 SCID mice to dissemination of endodontic infections. Infect Immun 1997;65:3781-7.
25. Kawashima N, Niederman R, Hynes RO, Ullmann-Cullere M, Stashenko P. Infection-stimulated infraosseous inflammation and bone destruction is increased in P-/E-selectin knockout mice. Immunology 1999;97:117-23.
26. Hou L, Sasakj H, Stashenko P. B-cell deficiency predisposes mice to disseminating anaerobic infections: protection by passive antibody transfer. Infect Immun 2000;68:5645-51.
27. Fouad AF. IL-1 alpha and TNF-alpha expression in early periapical lesions of normal and immunodeficient mice. J Dent Res 1997;76:1548-54.
28. Stashenko P, Yu SM. T helper and T suppressor cell reversal during the development of induced rat periapical lesions. J Dent Res 1989;68:830-4.
29. Liu Z, Simpson RJ, Cheers C. Role of IL-6 in activation of T cells for acquired cellular resistance to Listeria monocytogenes. J Immunol 1994;152:5375-80.
30. Rifas L. Bone and cytokines: beyond IL-1, IL-6 and TNF-alpha [editorial]. Calcif Tissue Int 1999;64:1-7.
31. Jilka RL, Hangoc G, Girasole G, Passeri G, Williams DC, Abrams JS, et al. Increased osteoclast development after estrogen loss: mediation by interleukin-6. Science 1992;257:88-91.
32. Hou L, Sasaki H, Stashenko P. Toll-like receptor 4-deficient mice have reduced bone destruction following mixed anaerobic infection. Infect Immun 2000;68:4681-7.
33. Anderson DM, Maraskovsky E, Billingsley WL, Dougall WC, Tometsko ME, Roux ER, et al. A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 1997;390:175-9.
34. Wong BR, Rho J, Arron J, Robinson E, Orlinick J, Chao M, et al. TRANCE is a novel ligand of the tumor necrosis factor receptor family that activates c-Jun N-terminal kinase in T cells. J Biol Chem 1997;272:25190-4.
35. Lacey DL, Timms E, Tan HL, Kelley MJ, Dunstan CR, Burgess T, et al. Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation. Cell 1998;93:165-76.
36. Dougall WC, Glaccum M, Charrier K, Rohrbach K, Brasel K, De Smedt T, et al. RANK is essential for osteoclast and lymph node development. Genes Dev 1999;13:2412-24.
37. Li J, Sarosi I, Yan XQ, Morony S, Capparelli C, Tan HL, et al. RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc Natl Acad Sci USA 2000;97:1566-71.